Mink Therapeutics Inc
NASDAQ:INKT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Mink Therapeutics Inc
NASDAQ:INKT
|
US |
|
A
|
ANTA Sports Products Ltd
XBER:AS7
|
CN |
|
P
|
Procter & Gamble Co
BMV:PG
|
US |
|
S
|
Suncor Energy Inc
F:SM3
|
CA |
|
LK Technology Holdings Ltd
F:L5D
|
HK |
|
M
|
McCormick & Company Inc
DUS:MCX
|
US |
|
E
|
Equinix Inc
F:EQN2
|
US |
|
C
|
Commerzbank AG
F:CBK
|
DE |
|
A
|
Allegion PLC
SWB:60A
|
IE |
|
C
|
Carpenter Technology Corp
F:XTY
|
US |
Wall St Price Targets
INKT Price Targets Summary
Mink Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INKT's stock price target?
Price Target
39.78
USD
According to Wall Street analysts, the average 1-year price target for
INKT is 39.78 USD with a low forecast of 35.35 USD and a high forecast of 45.15 USD.